Prediction and diagnosis of bladder cancer recurrence based on urinary content of hTERT, SENP1, PPP1CA, and MCM5 transcripts
about
MUMAL: multivariate analysis in shotgun proteomics using machine learning techniquesBiomarkers for non-muscle invasive bladder cancer: Current tests and future promiseDiagnosis of bladder cancer recurrence based on urinary levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 hypermethylationInhibition of p53 deSUMOylation exacerbates puromycin aminonucleoside-induced apoptosis in podocytes.A study of gene expression markers for predictive significance for bevacizumab benefit in patients with metastatic colon cancer: a translational research study of the Hellenic Cooperative Oncology Group (HeCOG)The metastasis suppressor NME1 regulates expression of genes linked to metastasis and patient outcome in melanoma and breast carcinoma.The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletionUrine telomerase for diagnosis and surveillance of bladder cancer.A Pilot Study on the Potential of RNA-Associated to Urinary Vesicles as a Suitable Non-Invasive Source for Diagnostic Purposes in Bladder Cancer.The regulatory roles of phosphatases in cancer.Nucleic acid-based biomarkers in body fluids of patients with urologic malignancies.Molecular markers in bladder cancer: Novel research frontiers.Role of protein phosphatases in genitourinary cancers.SUMO and the robustness of cancer.[Urine cytology - update 2013. A systematic review of recent literature].Cancer-specific promoters for expression-targeted gene therapy: ran, brms1 and mcm5.Coordinated downregulation of Spinophilin and the catalytic subunits of PP1, PPP1CA/B/C, contributes to a worse prognosis in lung cancer.MCMs expression in lung cancer: implication of prognostic significance.The role of sentrin-specific protease 2 substrate recognition in TGF-β-induced tumorigenesis.
P2860
Q21266684-01DA2227-0E2E-477C-B7C9-666104FF1697Q26775990-3F3CC857-5AFF-4DFF-9C65-5CFD74835B9AQ34441297-B9F86617-3901-4060-8CDB-27D239749DB9Q34685759-F10CE8AE-D85B-42B4-A27E-ED2C6D289BE6Q35099067-C7CBEDD7-CF6B-40E3-90C6-DA3B6C714574Q35536511-DAF2F35D-0089-4F91-891F-71176E2F3A5CQ35706611-453028CE-9800-4758-B57A-F65B6DAE6D00Q36134957-0A11B940-5462-4042-9896-32DB7E2BB4E3Q37693488-3D4A919E-1DBB-47D6-AF5A-85158B8162D9Q38090432-DD5D5E84-FE5A-43A3-8AFA-E11BE77EA755Q38216129-09116F56-A4AC-4A51-93FA-689B1E030ADAQ38520403-413A8070-E495-4034-B40B-C6D116D44034Q38941676-407A1AB5-5499-4561-94E0-3F54F273FC0CQ39108925-FF3A3440-3AE7-4BCC-9C20-3840AD1C7957Q45139625-25A4E99E-037C-4C10-B95E-794E094D638EQ45885614-75AD7F46-A702-46EB-B4F8-6B7AE6E99192Q47100472-9A34D141-E4B8-47A7-84CE-0621A179C3B1Q47157785-5406FEA5-6B44-454F-B041-E8D26B73818DQ55514789-E2C30974-7DE8-45A6-AC16-07A2A0C51CB0
P2860
Prediction and diagnosis of bladder cancer recurrence based on urinary content of hTERT, SENP1, PPP1CA, and MCM5 transcripts
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Prediction and diagnosis of bl ...... , PPP1CA, and MCM5 transcripts
@ast
Prediction and diagnosis of bl ...... , PPP1CA, and MCM5 transcripts
@en
type
label
Prediction and diagnosis of bl ...... , PPP1CA, and MCM5 transcripts
@ast
Prediction and diagnosis of bl ...... , PPP1CA, and MCM5 transcripts
@en
prefLabel
Prediction and diagnosis of bl ...... , PPP1CA, and MCM5 transcripts
@ast
Prediction and diagnosis of bl ...... , PPP1CA, and MCM5 transcripts
@en
P2093
P2860
P356
P1433
P1476
Prediction and diagnosis of bl ...... , PPP1CA, and MCM5 transcripts
@en
P2093
Anne Sofie Brems-Eskildsen
Francisco Mansilla
Helle Toldbod
Karsten Zieger
Michael Borre
Pia P Munksgaard
Russell Higuchi
Torben F Ørntoft
P2860
P2888
P356
10.1186/1471-2407-10-646
P407
P577
2010-11-24T00:00:00Z
P5875
P6179
1022960944